Zoekresultaten - 16 results
Synthetic Biology. Latest developments, biosafety considerations and regulatory challenges
stakeholders. It is important to note that SB is a rapidly evolving field encompassing many different topics. It is therefore worth mentioning that this document does not aim at providing an exhaustive overview ...
Feasibility study on drug consumption rooms in Belgium
neighbouring countries; (2) conduct an in-depth analysis of the legal framework within a DCR could operate in Belgium; and (3) conduct a feasibility study with local stakeholders and PWUD from each of the five ...
Reitox national reporting to EMCDDA on drugs and drug addiction, 2021
transfer of the national drug-related information, which allows the Centre to better address the needs for information of European and National Stakeholders. IT he newly implemented reporting tool does ...
Reitox national reporting to EMCDDA on drugs and drug addiction, 2018
drug-related information, which allows the Centre to better address the needs for information of European and National Stakeholders. IT he newly implemented reporting tool does no result in a standalone document ...
Final report: MY DNA, EVERYBODY’S BUSINESS? Qualitative analysis of the belgian citizen forum on the use of genomic information
society and formulate recommendations for the Minister of Public Health and all stakeholders of this field. The statement “My DNA is my property because it is the most intimate part of an individual” is an ...
IPAAC Rapport WP4: Cancer control policy interview survey
reported having pursued innovative approaches to better inform and communicate with key stakeholders, especially related to children, adolescents and young adults (AYA s) and lower socio-economic groups. ...